Table 1 Clinical details of patients with schizophrenia (N = 32).
ID Patients with schizophrenia | ||||||||||||||||||||||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | |
Sex | M | F | F | M | M | M | M | M | F | M | M | M | M | M | M | M | M | M | M | F | M | M | M | M | M | F | M | M | F | M | M | F |
Age | 56 | 48 | 44 | 23 | 35 | 53 | 30 | 40 | 38 | 53 | 30 | 31 | 24 | 43 | 26 | 35 | 45 | 22 | 27 | 49 | 50 | 47 | 43 | 57 | 47 | 24 | 47 | 25 | 56 | 30 | 47 | 46 |
Education (Yrs) | 8 | 13 | 13 | 13 | 8 | 11 | 8 | 13 | 8 | 13 | 13 | 13 | 10 | 13 | 13 | 8 | 14 | 13 | 8 | 13 | 10 | 8 | 13 | 8 | 8 | 13 | 8 | 8 | 8 | 8 | 8 | 8 |
Treatment | ||||||||||||||||||||||||||||||||
Typical neuroleptics | • | • | • | • | • | • | • | |||||||||||||||||||||||||
Atypical neuroleptics | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | • | |||||||||
PANSS | ||||||||||||||||||||||||||||||||
Negative symptoms | 10 | 21 | 17 | 13 | 35 | 17 | 42 | 18 | 7 | 19 | 33 | 16 | 15 | 42 | 20 | 16 | 21 | 15 | 11 | 18 | 24 | 29 | 8 | 11 | 32 | 25 | 22 | 14 | 11 | 42 | 29 | 12 |
Positive symptoms | 12 | 9 | 9 | 13 | 22 | 18 | 42 | 29 | 10 | 25 | 34 | 23 | 12 | 31 | 18 | 14 | 10 | 10 | 17 | 18 | 26 | 20 | 25 | 18 | 29 | 23 | 11 | 16 | 7 | 42 | 13 | 9 |
General symptoms | 30 | 51 | 32 | 39 | 62 | 24 | 94 | 41 | 32 | 36 | 88 | 48 | 37 | 69 | 31 | 32 | 40 | 29 | 40 | 35 | 58 | 38 | 8 | 32 | 64 | 53 | 48 | 24 | 16 | 94 | 40 | 26 |
Total score | 52 | 81 | 58 | 65 | 119 | 59 | 178 | 88 | 49 | 80 | 155 | 87 | 64 | 142 | 69 | 62 | 71 | 54 | 68 | 71 | 108 | 87 | 33 | 61 | 125 | 101 | 81 | 54 | 34 | 178 | 82 | 47 |